These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 7815014

  • 21. Drug-induced long QT syndrome and torsade de pointes.
    Morissette P, Hreiche R, Turgeon J.
    Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909
    [Abstract] [Full Text] [Related]

  • 22. A practical approach to torsade de pointes.
    Roden DM.
    Clin Cardiol; 1997 Mar; 20(3):285-90. PubMed ID: 9068917
    [Abstract] [Full Text] [Related]

  • 23. [CME ECG 66/Answers: Torsade de Pointes: The Danger of a Rotating Heart Axis].
    Markendorf S, Saguner AM, Brunckhorst C.
    Praxis (Bern 1994); 2020 Mar; 109(13):1035-1038. PubMed ID: 33050812
    [Abstract] [Full Text] [Related]

  • 24. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.
    Hii JT, Wyse DG, Gillis AM, Duff HJ, Solylo MA, Mitchell LB.
    Circulation; 1992 Nov; 86(5):1376-82. PubMed ID: 1423949
    [Abstract] [Full Text] [Related]

  • 25. Torsades de pointes associated with terfenadine in a case of liver cirrhosis and hepatocellular carcinoma.
    Kamisako T, Adachi Y, Nakagawa H, Yamamoto T.
    Intern Med; 1995 Feb; 34(2):92-5. PubMed ID: 7727886
    [Abstract] [Full Text] [Related]

  • 26. Proarrhythmic potential of halofantrine, terfenadine and clofilium in a modified in vivo model of torsade de pointes.
    Batey AJ, Coker SJ.
    Br J Pharmacol; 2002 Feb; 135(4):1003-12. PubMed ID: 11861329
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Fluconazole-associated QT interval prolongation and Torsades de Pointes in a paediatric patient.
    Ünal Yüksekgönül A, Ertuğrul İ, Karagöz T.
    Cardiol Young; 2021 Dec; 31(12):2035-2037. PubMed ID: 34024302
    [Abstract] [Full Text] [Related]

  • 32. Torsade de pointes.
    Roden DM.
    Clin Cardiol; 1993 Sep; 16(9):683-6. PubMed ID: 7902224
    [Abstract] [Full Text] [Related]

  • 33. Cardiac actions of antihistamines.
    Woosley RL.
    Annu Rev Pharmacol Toxicol; 1996 Sep; 36():233-52. PubMed ID: 8725389
    [Abstract] [Full Text] [Related]

  • 34. Drug-induced QTC prolongation dangerously underestimates proarrhythmic potential: lessons from terfenadine.
    Hondeghem LM, Dujardin K, Hoffmann P, Dumotier B, De Clerck F.
    J Cardiovasc Pharmacol; 2011 May; 57(5):589-97. PubMed ID: 21346598
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Iatrogenic torsade de pointes induced by thioridazine].
    Paoloni P, Ciliberti D, Blasi N, Capone P.
    Minerva Cardioangiol; 1992 Jun; 40(6):245-9. PubMed ID: 1407620
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Torsade de pointes induced by ajmaline.
    Haverkamp W, Mönnig G, Kirchhof P, Eckardt L, Borggrefe M, Breithardt G.
    Z Kardiol; 2001 Aug; 90(8):586-90. PubMed ID: 11565214
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.